Dr. Agarwal's Health Care Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Dr. Agarwal's Health Care Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Profit Cash Ratio: Over the last 3 years, every ₹100 of reported profit came with ₹408 of operating cash. Higher than 97% of Healthcare companies in India.
- Tangible Net Worth Ratio: Of every ₹100 of net worth, ₹43 is tangible; the rest is goodwill and other intangibles, often from buying other companies. Less tangible than 90% of Healthcare companies in India.
- Tangible Assets Ratio: Of every ₹100 the company owns, ₹71 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 89% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹408Over the last 3 years, every ₹100 of reported profit came with ₹408 of operating cash.
Higher than 97% of Healthcare companies in India.
Self-Funding Ratio
1.2×Over the last 3 years its own operating cash covered its investment spending (capex) 1.2 times.
Lower than 57% of Healthcare companies in India.
Cash Locked Ratio
₹2For every ₹100 of sales, ₹2 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹4 from others' credit three years earlier.
Less money tied up than 85% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 53% of Healthcare companies in India.
Growth Efficiency Ratio
₹4Sales grew 104% in 3 years; of every extra ₹100 of sales, ₹4 became extra profit.
Lower than 81% of Healthcare companies in India.
Asset Productivity Ratio
+104% / +116%In 3 years sales changed by +104% while total assets changed by +116%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
21.7×Debt due within a year is covered 21.7 times by its yearly operating cash.
Higher than 84% of Healthcare companies in India.
Cash Cushion Ratio
−5%Debt, after subtracting cash, equals 5% of its market value (net debt).
Lower than 67% of Healthcare companies in India.
Tangible Assets Ratio
71%Of every ₹100 the company owns, ₹71 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 89% of Healthcare companies in India.
Tangible Net Worth Ratio
43%Of every ₹100 of net worth, ₹43 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 90% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Dr. Agarwal's Health Care Limited owes ₹0.46 for every ₹1 it owns. Net profit rose 60% in the year to Mar 2026, and grew 12% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
101.9Investors pay ₹101.9 for every ₹1 of Dr. Agarwal's Health Care Limited's yearly profit, higher than 91% of Healthcare companies in India.
P/B ratio
7.42The share price is 7.42 times Dr. Agarwal's Health Care Limited's book value per share, higher than 77% of Healthcare companies in India.
Market cap
₹15,024 CrThe total market value of all of Dr. Agarwal's Health Care Limited's shares at today's price (share price × number of shares), larger than 73% of Healthcare companies in India. PosiCap size class: Meso Cap.
Net worth (book value)
₹2,025 CrWhat Dr. Agarwal's Health Care Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹63.89Net worth divided by the number of shares. The share price of ₹473.90 is 7.4 times this, which is the P/B above.
Return on equity (ROE)
7.3%Dr. Agarwal's Health Care Limited earned 7.3% on its shareholders' money over the last year, lower than 78% of Healthcare companies in India.
Owes vs Owns
0.46×Dr. Agarwal's Health Care Limited owes ₹0.46 for every ₹1 it owns (low), higher than 75% of Healthcare companies in India.
Dividend yield
NoneDr. Agarwal's Health Care Limited does not currently pay a dividend.
Revenue growth
+22%Revenue rose 22% in the year to Mar 2026, and grew 27% a year on average over 3 years.
Profit growth
+60%Net profit rose 60% in the year to Mar 2026, and grew 12% a year on average over 3 years.
Profit margin
6.4%Dr. Agarwal's Health Care Limited keeps ₹6 of every ₹100 of revenue as net profit.
Cash quality
3.9×Cash from Dr. Agarwal's Health Care Limited's business was 3.9× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
3.4×Dr. Agarwal's Health Care Limited's operating profit covered its interest costs 3.4 times in the year to Mar 2026.
Cash vs debt
Net debtDr. Agarwal's Health Care Limited had ₹782 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Dr. Agarwal's Health Care Limited's P/E ratio?
Investors pay ₹101.9 for every ₹1 of Dr. Agarwal's Health Care Limited's yearly profit, higher than 91% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Dr. Agarwal's Health Care Limited: ₹15,024 Cr ÷ ₹2,025 Cr (31 Mar 2026) = 7.4.
What is Dr. Agarwal's Health Care Limited's return on equity?
Dr. Agarwal's Health Care Limited earned 7.3% on its shareholders' money over the last year, lower than 78% of Healthcare companies in India.
How much does Dr. Agarwal's Health Care Limited owe compared with what it owns?
Dr. Agarwal's Health Care Limited owes ₹0.46 for every ₹1 it owns (low), higher than 75% of Healthcare companies in India.
Does Dr. Agarwal's Health Care Limited pay a dividend?
No. Dr. Agarwal's Health Care Limited does not currently pay a dividend.
Is Dr. Agarwal's Health Care Limited's revenue growing?
Revenue rose 22% in the year to Mar 2026, and grew 27% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.